Summit Trail Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.23M Buy
225,492
+143,006
+173% +$802K 0.02% 837
2025
Q4
$577K Buy
82,486
+30,109
+57% +$236K 0.01% 1033
2025
Q3
$405K Buy
+52,377
New +$409K 0.01% 1138
2025
Q2
Sell
-17,978
Closed -$143K 1143
2025
Q1
$143K Buy
17,978
+7,819
+77% +$79.1K ﹤0.01% 395
2024
Q4
$92.3K Buy
+10,159
New +$98.1K ﹤0.01% 383
2022
Q2
Sell
-6,161
Closed -$444K 414
2022
Q1
$444K Buy
6,161
+2,956
+92% +$213K 0.04% 192
2021
Q4
$294K Buy
3,205
+265
+9% +$31.7K 0.02% 234
2021
Q3
$373K Sell
2,940
-79
-3% -$11.5K 0.03% 184
2021
Q2
$502K Buy
3,019
+833
+38% +$135K 0.04% 139
2021
Q1
$397K Sell
2,186
-14
-0.6% -$3.25K 0.04% 136
2020
Q4
$440K Buy
+2,200
New +$447K 0.06% 123
2018
Q4
Sell
-2,519
Closed -$218K 211
2018
Q3
$218K Sell
2,519
-67
-3% -$4.78K 0.05% 181
2018
Q2
$150K Buy
+2,586
New +$126K 0.05% 163
2018
Q1
Sell
-1,884
Closed -$66K 1519
2017
Q4
$66K Buy
+1,884
New +$62.6K 0.01% 748

Other funds holding TDOC

Summit Trail Advisors's TDOC Position: Q1 2026 in Review

Summit Trail Advisors increased its Teladoc Health (TDOC) stake by 173% in Q1 2026, buying an estimated $802K and bringing the position to 225,492 shares worth $1.23M. The position accounts for 0.02% of the portfolio, ranked #837.

Summit Trail Advisors first reported a position in TDOC in Q4 2017 and has held it in 14 quarters since. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Summit Trail Advisors held 225,492 shares of Teladoc Health worth $1.23M as of Q1 2026.
  • Summit Trail Advisors bought 143,006 Teladoc Health shares in Q1 2026, an estimated $802K.
  • Teladoc Health made up 0.02% of Summit Trail Advisors's portfolio in Q1 2026, its #837 holding.
  • Summit Trail Advisors first reported a position in Teladoc Health in Q4 2017 and has held it in 14 quarters since.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.